Delivery Order SPE2DB24D3014-SPE2DB25FKRUV

Award Date 10/16/24
Potential Completion Date 10/17/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,921.15 firm fixed-price contract is for the supply of the medication Mounjaro (7.5 mg/0.5 ml pen, 0.5 ml) to support military healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,836.38, is for the procurement of the medication Mounjaro 5 mg/0.5 ml pen in 0.5 ml quantities. The award has an ultimate completion date of May 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $11,844.52. The award is for MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC provides a comprehensive range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,586.68, is for the supply of the medication Mounjaro 10 mg/0.5 ml pen in 0.5 ml quantities. The contract has a period of performance running through October 24, 2024 and is a firm fixed-price delivery order contract. This award is likely part of a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $6,128.89. The contract is for the procurement of the medication Mounjaro 7.5 mg/0.5 ml pen, a 0.5 ml dose. It is a firm fixed-price contract with a period of performance through March 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,071.30, is for the procurement of the drug Mounjaro, a 5 mg/0.5 ml medication pen. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $5,294.64, is for the drug Mounjaro 2.5 mg/0.5 ml pen 0.5 ml. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $17,083.53, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,710.16, is for the supply of the medication Mounjaro 10 mg/0.5 mL pen, a 0.5 mL product. The delivery order has a firm fixed price and an ultimate completion date of December 3, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $16,257.11 and a period of performance through May 23, 2024. The award is for the supply of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
  • SPE2DB24D3014
    Indefinite Delivery Contract
  • SPE2DB24D3014-SPE2DB25FKRUV
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,968.83, is for the procurement of the medication Mounjaro (7.5 mg/0.5 ml pen). The award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 1/15/25, 9:18 AM